Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04230967 · ClinicalTrials.gov registry record · NA

Ambulation for Latency During Expectant Management of PPROM

A NA study, sponsored by The University of Texas Health Science Center, Houston.

Completed
Registry status
NA
Development phase
100
Enrollment target

NCT04230967 is a NA study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 100 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04230967, a NA study, has completed, sponsored by The University of Texas Health Science Center, Houston.

COMPLETED
Registry status
NA
Development phase
100 participants
Enrollment target

Study Summary

Ambulation in pregnancy has been proposed to decrease stress and anxiety, increasing preterm birth. Whether ambulation is causally related to latency is unknown. The FitBit will be used for tracking the number of steps taken daily by each participant, and for encouraging the intervention group to walk. The FitBit is the most widely used physical activity tracker in medical research, and its use has been validated for research use in pregnant women. The purpose of the study is to evaluate whether ambulation in patients with preterm premature rupture of the membranes (PPROM) prolongs latency.

Interventions

  • BEHAVIORAL Routine Care
  • BEHAVIORAL Ambulation Group

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2020-03-10
Est. Completion 2023-03-30
Phase NA

What the Registry Record Tells You About NCT04230967

The ClinicalTrials.gov registry entry for NCT04230967 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Routine Care is the first listed.

NCT04230967 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04230967 about?

NCT04230967 is a clinical study titled "Ambulation for Latency During Expectant Management of PPROM". Ambulation in pregnancy has been proposed to decrease stress and anxiety, increasing preterm birth. Whether ambulation is causally related to latency is unknown. The FitBit will be used for tracking the number of steps taken daily by each participant, and for encouraging the intervention group to wa...

What is the current status of trial NCT04230967?

This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2020-03-10. Estimated completion is 2023-03-30.

What interventions are being tested in trial NCT04230967?

The interventions under investigation include: Routine Care (BEHAVIORAL), Ambulation Group (BEHAVIORAL).

Who is sponsoring clinical trial NCT04230967?

This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.